1. Start with the Great name of ALLAH, the most
merciful and the most Beneficent
2. A 44 year female present with new onset of seizures for
last 5 months, Generalize tonic clonic in nature,
associate with headache. KPS score 80 with intact
neurology.
3.
4. Left parietal Craino-tomy with inter-hemispheric
microsurgical resection with stereotactic neuro-
navigation were performed and biopsy came to be
Diffuse Astrocytoma IDH mutant
7. General Information
• IDH1 and IDH2
• Children and young adults
• 5% of primary brain tumors, 15% of all glioma
• Pediatric age < 20 year, IDH mutation (0.26) occur half
that of adult (0.48); less malignant degeneration
• Locations; temporal, posterior frontal, anterior parietal
lobe (adults); thalamus (pediatric)
8. Pathology
• Low degrees cellularity
• Highly differentiated cells
• Prevention of normal element
• Calcification are rare
• Anaplasia and mitosis absent
• Blood vessels slightly inc
• Stain positive for GFAP
11. Treatment
• No treatment for static tumor
• Radiation
• Chemotherapy
• Surgery
• Radiation and chemotherapy together with or with out
surgery
12. Surgery
• Goals; Histological confirmation, neurological condition,
reduce risk of tumor growth, to prevent malignant
transformation
• Pre- operative WHO grading; age > 50. KPS <80,
eloquent brain, Max diameter >4cm
• Intra-operative mapping and awake craniotomy
13. Adjuvant therapy
• No affect on overall survival
• Radically remove tumor doesn’t need radiotherapy
• Incomplete resection can increase Progression free
survival
• Chemotherapy; for dedifferentiation, progressive tumor
14. Prognosis
• Median survival 10.9 years
• Worse prognosis variables; age >40, astrocytoma
Histology, diameter>6 cm, tumor crossing midline,
neurological deficit
• Sum of score of WHO class(score, 5yr OS and PFS); 0-1,
97%, 76%; 2, 81%, 49%; 3-4, 56%, 18%.
15. Dedifferentiation
• 75% adult tumor undergoes anaplastic or glioblastoma
• More rapid if diagnosed after 45 years
• Once occur; survival rate (2-3 years)
16. Gemistocytic Astrocytoma
• >20% tumor cells and 10% of diffuse astrocytoma
• Mean age 40 years
• Histology; glassy, plump, angular eosinophilic cells and
contain GFAP- Positive cell process
• TP53 +ve >80%
• No imaging difference
• Dedifferentiate earlier and worse outcome
17. Diffuse Astrocytoma (wild Type)
• Rare
• Doesn’t have IDH mutation
• Variety of tumor further classified with additional genetic
testing
• Doesn’t have WHO grade
18.
19. Diffusion Astrocytoma, NOS
• Histological resemblance with diffuse astrocytoma
• IDH levels not satisfactorily identified
• Diagnosis of exclusion
• No WHO classification.